Literature DB >> 18287450

Quantitative assessment of air trapping in chronic obstructive pulmonary disease using inspiratory and expiratory volumetric MDCT.

Shin Matsuoka1, Yasuyuki Kurihara, Kunihiro Yagihashi, Makoto Hoshino, Naoto Watanabe, Yasuo Nakajima.   

Abstract

OBJECTIVE: The purpose of our study was to determine the attenuation threshold value for the detection and quantification of air trapping using paired inspiratory and expiratory volumetric MDCT scans and to assess whether the densitometric parameter can be used for the quantification of airway dysfunction in chronic obstructive pulmonary disease (COPD) regardless of the degree of emphysema.
MATERIALS AND METHODS: This study included 36 patients with COPD who underwent 64-MDCT. The entire lung volume with attenuation between -500 and -1,024 H was segmented as whole lung. The lung volume with attenuation between -500 and -950 H was segmented as limited lung, while the lung volume of less than -950 H was segmented as emphysema and eliminated. The relative volumes for limited lung (relative volume(n-950)) with attenuation values below thresholds (n) ranging from -850 to -950 H, and relative volume for whole lung (relative volume(<n)) were obtained on inspiratory and expiratory CT. Then the differences of relative volumes after expiration in whole lung (relative volume change(<n)) and limited lung (relative volume change(n-950)) were calculated. Patients were classified into two groups according to mean relative volume less than -950 H. Correlations between densitometry parameters and pulmonary function tests (PFTs) reflecting airway dysfunction were evaluated.
RESULTS: The highest correlation with PFTs was observed at the upper threshold of -860 H. In the moderate to severe emphysema group (relative volume(<-950) > 15%), relative volume change(860-950) significantly correlated with the results of PFTs, whereas no significant correlations were seen between relative volume change(<-860) and PFTs. In the minimal or mild emphysema group (inspiratory relative volume(<-950) < 15%), all densitometric parameters correlated with PFTs.
CONCLUSION: The densitometric parameter of relative volume change calculated on paired inspiratory and expiratory MDCT using the threshold of -860 H in limited lung correlated closely with airway dysfunction in COPD regardless of the degree of emphysema.

Entities:  

Mesh:

Year:  2008        PMID: 18287450     DOI: 10.2214/AJR.07.2820

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  67 in total

1.  Quantative computerized tomography assessment of lung density as a predictor of postoperative pulmonary morbidity in patients with lung cancer.

Authors:  Tevfik Kaplan; Gokce Kaan Atac; Nesimi Gunal; Bulent Kocer; Aslıhan Alhan; Sezai Cubuk; Orhan Yucel; Ebru Ozan Sanhal; Koray Dural; Serdar Han
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

2.  Density-based MDCT quantification of lobar lung volumes: a study of inter- and intraobserver reproducibility.

Authors:  F Molinari; M Amato; M Stefanetti; G Parapatt; A Macagnino; G Serricchio; T Pirronti; L Bonomo
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

3.  Tidal changes on CT and progression of ARDS.

Authors:  Maurizio Cereda; Yi Xin; Hooman Hamedani; Giacomo Bellani; Stephen Kadlecek; Justin Clapp; Luca Guerra; Natalie Meeder; Jennia Rajaei; Nicholas J Tustison; James C Gee; Brian P Kavanagh; Rahim R Rizi
Journal:  Thorax       Date:  2017-06-20       Impact factor: 9.139

4.  American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.

Authors:  Prescott G Woodruff; Maarten van den Berge; Richard C Boucher; Christopher Brightling; Esteban G Burchard; Stephanie A Christenson; MeiLan K Han; Michael J Holtzman; Monica Kraft; David A Lynch; Fernando D Martinez; Helen K Reddel; Don D Sin; George R Washko; Sally E Wenzel; Antonello Punturieri; Michelle M Freemer; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

5.  Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Craig J Galbán; Jennifer L Boes; Maria Bule; Carrie L Kitko; Daniel R Couriel; Timothy D Johnson; Vihba Lama; Eef D Telenga; Maarten van den Berge; Alnawaz Rehemtulla; Ella A Kazerooni; Michael J Ponkowski; Brian D Ross; Gregory A Yanik
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-18       Impact factor: 5.742

6.  Imaging Small Airway Disease: Probabilities and Possibilities.

Authors:  Surya P Bhatt
Journal:  Ann Am Thorac Soc       Date:  2019-08

Review 7.  The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease.

Authors:  Wassim W Labaki; Carlos H Martinez; Fernando J Martinez; Craig J Galbán; Brian D Ross; George R Washko; R Graham Barr; Elizabeth A Regan; Harvey O Coxson; Eric A Hoffman; John D Newell; Douglas Curran-Everett; James C Hogg; James D Crapo; David A Lynch; Ella A Kazerooni; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

8.  A CT Scan Harmonization Technique to Detect Emphysema and Small Airway Diseases.

Authors:  Gonzalo Vegas-Sánchez-Ferrero; Raúl San Estépar José
Journal:  Image Anal Mov Organ Breast Thorac Images (2018)       Date:  2018-09-12

9.  Assessment of lung volume collapsibility in chronic obstructive lung disease patients using CT.

Authors:  Shinjini Kundu; Suicheng Gu; Joseph K Leader; John R Tedrow; Frank C Sciurba; David Gur; Naftali Kaminski; Jiantao Pu
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

10.  Early identification of small airways disease on lung cancer screening CT: comparison of current air trapping measures.

Authors:  Onno M Mets; Pieter Zanen; Jan-Willem J Lammers; Ivana Isgum; Hester A Gietema; Bram van Ginneken; Mathias Prokop; Pim A de Jong
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.